TrialCell transplantation

Post-Hoc Analysis of a Randomized, Double Blind, Prospective Study at the University of Chicago: Additional Standardizations of Trial Protocol are Needed to Evaluate the Effect of a CXCR1/2 Inhibitor in Islet Allotransplantation.

Piotr J Bachul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.